Press Releases

Active Biotech AB: Interim report January – June 2019
August 8, 2019 08:30 (CEST)
Regulatory
Annual General Meeting of Active Biotech AB
May 23, 2019 20:00 (CEST)
Regulatory
The Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at the scientific conference "American Academy of Neurology - AAN" in Philadelphia, PA, on May 6 2019
May 3, 2019 13:00 (CEST)
Regulatory
The Election Committee of Active Biotech AB proposes Michael Shalmi to be appointed new Chairman of the Board and Uli Hacksell to be appointed new member of the Board
May 2, 2019 13:00 (CEST)
Regulatory
Annual Report 2018 Active Biotech AB (publ)
April 26, 2019 11:00 (CEST)
Regulatory
Active Biotech AB - Interim report January - March 2019
April 25, 2019 08:30 (CEST)
Regulatory
Active Biotech: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
April 24, 2019 13:00 (CEST)
Regulatory
Active Biotech completes sale of property
April 5, 2019 14:15 (CEST)
Regulatory
Extraordinary General Meeting of Active Biotech AB
April 4, 2019 18:00 (CEST)
Regulatory
NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING OF ACTIVE BIOTECH AB (PUBL)
March 13, 2019 18:15 (CET)
Regulatory